Sharenet Sites 
Sharenet Sites
Results of Annual General Meeting
ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049 JSE Code: AVL
RESULTS OF ANNUAL GENERAL MEETING (“AGM”)
INTRODUCTION
Further to the announcement released on SENS on 2 October 2017, shareholders are advised that at
the AGM of Advanced Health held on 23 October 2017, convened in terms of the notice of AGM contained
in the Integrated Report for the year ended 30 June 2017, all the ordinary and special resolutions
as proposed were approved by the requisite majority.
RESULTS
Number of ordinary shares represented at the meeting 216 324 480
Total issued number of ordinary shares in issue 287 988 433
Percentage of ordinary shares represented at the meeting 75.12%
Ordinary Resolutions
Ordinary resolution number 1 Appointment of CP Snyman as CFO
For Against Abstentions (2) Shares voted (3)
216 247 420 - 77 060
100.00% 0.00% 0.03% 75.09%
Ordinary resolution number 2.1: Approval of PJ Jaffe as director
For Against Abstentions (2) Shares voted (3)
211 501 603 - 4 822 877
100.00% 0.00% 1.67% 73.44%
Ordinary resolution number 2.2: Approval of FA van Hoogstraten as director
For Against Abstentions (2) Shares voted (3)
216 247 420 - 77 060
100.00% 0.00% 0.03% 75.09%
Ordinary resolution number 3: Approval of auditors
For Against Abstentions (2) Shares voted (3)
211 491 426 4 745 817 87 237
97.81% 2.19% 0.03% 73.44%
Ordinary resolution number 4: Approval of Mr PJ Jaffe as member and chairman of the audit and risk
committee
For Against Abstentions (2) Shares voted (3)
211 501 603 4 745 817 77 060
97.81% 2.19% 0.03% 73.44%
Ordinary resolution number 5.1: Approval of Dr WT Mthembu as member and chairman of the audit and
risk committee
For Against Abstentions (2) Shares voted (3)
209 352 489 2 149 114 4 822 877
98.98% 1.02% 1.67% 73.44%
Ordinary resolution number 5.2: Approval of Mr FA van Hoogstraten as member and chairman of the audit
and risk committee
For Against Abstentions (2) Shares voted (3)
209 275 037 2 226 566 4 822 877
98.95% 1.05% 1.67% 73.44%
Ordinary resolution number 6: Approval of the company’s remuneration policy
For Against Abstentions (2) Shares voted (3)
193 049 098 18 435 830 4 839 552
91.28% 8.72% 1.68% 73.44%
Ordinary resolution number 7: General power and authority to allot and issue shares for cash
For Against Abstentions (2) Shares voted (3)
193 050 465 23 196 955 77 060
89.27% 10.73% 0.03% 75.09%
Ordinary resolution number 8: Place the authorised but unissued shares under the control of the directors
For Against Abstentions (2) Shares voted (3)
211 393 432 4 858 582 72 466
97.75% 2.25% 0.03% 75.09%
Ordinary resolution number 9: General authority for directors and company secretary
For Against Abstentions (2) Shares voted (3)
216 247 420 - 77 060
100.00% 0.00% 0.03% 75.09%
Special resolution number 1: Approval of non-executive directors’ remuneration
For Against Abstentions (2) Shares voted (3)
216 201 232 20 000 103 248
99.99% 0.01% 0.04% 75.08%
Special resolution number 2: Financial assistance
For Against Abstentions (2) Shares voted (3)
211 486 692 4 755 817 81 971
97.80% 2.20% 0.03% 75.09%
Notes:
(1) The votes carried for and against each individual resolution are disclosed as a percentage in relation to
the total number of ordinary shares voted (whether in person or by proxy) in respect of such individual
resolution at the annual general meeting.
(2)The total number of ordinary shares abstained in respect of each individual resolution (whether in person
or by proxy) is disclosed as a percentage in relation to the total number of ordinary shares in issue.
(3) The total number of ordinary shares voted (whether in person or by proxy) at the annual general meeting
in respect of each individual resolution is disclosed as a percentage in relation to the total number of ordinary
shares in issue.
Johannesburg
24 October 2017
Designated Advisor
Grindrod Bank Limited
Date: 24/10/2017 10:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
